BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11861104)

  • 1. Preparation of beta-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice.
    Chimanuka B; Gabriëls M; Detaevernier MR; Plaizier-Vercammen JA
    J Pharm Biomed Anal; 2002 Apr; 28(1):13-22. PubMed ID: 11861104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the stage-specific efficacy of chloroquine, artemether and dioncophylline B against the rodent malaria parasite Plasmodium chabaudi chabaudi in vivo.
    Chimanuka B; François G; Timperman G; Heyden YV; Holenz J; Plaizier-Vercammen J; Bringmann G
    Parasitol Res; 2001 Oct; 87(10):795-803. PubMed ID: 11688884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model.
    Patil S; Suryavanshi S; Pathak S; Sharma S; Patravale V
    Int J Pharm; 2013 Oct; 455(1-2):229-34. PubMed ID: 23886650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
    Peters W; Stewart LB; Robinson BL
    Ann Trop Med Parasitol; 2005 Jul; 99(5):457-72. PubMed ID: 16004705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
    Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials.
    Peters W; Fleck SL; Robinson BL; Stewart LB; Jefford CW
    Ann Trop Med Parasitol; 2002 Sep; 96(6):559-73. PubMed ID: 12396319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.
    Isacchi B; Bergonzi MC; Grazioso M; Righeschi C; Pietretti A; Severini C; Bilia AR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):528-34. PubMed ID: 22142592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria.
    Karbwang J; Bangchang KN; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Lancet; 1992 Nov; 340(8830):1245-8. PubMed ID: 1359318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of artemether, methylparaben and propylparaben in a formulated paediatric antimalarial dry suspension.
    Atemnkeng MA; Marchand E; Plaizier-Vercammen J
    J Pharm Biomed Anal; 2007 Jan; 43(2):727-32. PubMed ID: 17074460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of erythrocytic stages of the rodent malaria parasite Plasmodium chabaudi chabaudi to dioncophylline B, a highly active naphthylisoquinoline alkaloid.
    François G; Chimanuka B; Timperman G; Holenz J; Plaizier-Vercammen J; Aké Assi L; Bringmann G
    Parasitol Res; 1999 Nov; 85(11):935-41. PubMed ID: 10540956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Additive therapeutic effect of a combination of artemether and daphnetin against Plasmodium berghei in mice].
    Guo J; Ni YC; Wu JT; Wang QM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):164-6. PubMed ID: 15597713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation.
    Patil S; Joshi M; Pathak S; Sharma S; Patravale V
    J Antimicrob Chemother; 2012 Nov; 67(11):2713-6. PubMed ID: 22899802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and chemical evaluation of liposomes, containing artesunate.
    Gabriëls M; Plaizier-Vercammen J
    J Pharm Biomed Anal; 2003 Mar; 31(4):655-67. PubMed ID: 12644192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance.
    Nnamani PO; Ugwu AA; Ibezim EC; Kenechukwu FC; Akpa PA; Ogbonna JN; Obitte NC; Odo AN; Windbergs M; Lehr CM; Attama AA
    Int J Nanomedicine; 2016; 11():6365-6378. PubMed ID: 27932882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
    Parashar D; Aditya NP; Murthy RS
    Drug Deliv; 2016; 23(1):123-9. PubMed ID: 24786480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Artemisia annua infusion efficacy for the treatment of malaria in Plasmodium chabaudi chabaudi infected mice.
    Atemnkeng MA; Chimanuka B; Dejaegher B; Heyden YV; Plaizier-Vercammen J
    Exp Parasitol; 2009 Aug; 122(4):344-8. PubMed ID: 19371743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
    Shmuklarsky MJ; Klayman DL; Milhous WK; Kyle DE; Rossan RN; Ager AL; Tang DB; Heiffer MH; Canfield CJ; Schuster BG
    Am J Trop Med Hyg; 1993 Mar; 48(3):377-84. PubMed ID: 8470775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.
    Joshi M; Pathak S; Sharma S; Patravale V
    Int J Pharm; 2008 Nov; 364(1):119-26. PubMed ID: 18765274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria.
    Looareesuwan S; Wilairatana P; Viravan C; Vanijanonta S; Pitisuttithum P; Kyle DE
    Am J Trop Med Hyg; 1997 Jun; 56(6):613-7. PubMed ID: 9230790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental studies on the antimalarial activity estimation by artesunate and artemether preparations per skin absorption.
    Xuan WY; Zhao Y; Li AY; Xie PS; Cai Y
    J Tradit Chin Med; 1988 Dec; 8(4):282-4. PubMed ID: 3073264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.